Skip to main content

Table 2 Baseline differences between drop-outs and finishers

From: Elastic band resistance training influences transforming growth factor-ß receptor I mRNA expression in peripheral mononuclear cells of institutionalised older adults: the Vienna Active Ageing Study (VAAS)

 

Total (n = 88)

Dropouts (n = 21)

Non-Dropouts (n = 67)

p-value

Gender [female/male]

77/11

18/3

59/8

0.777

Age [years]

84.5 (65.0–97.4)

85.2 (69.4–92.2)

84.2 (65.0–97.4)

0.282

BMI [kg/m2]

28.9 (18.1–50.0)

28.3 (18.1–43.7)

30.7 (23.4–50.0)

0.094

hs-CRP [mg/L]

1.9 (0.3–7.9)

2.0 (0.8–7.9)

1.9 (0.3–7.6)

0.413

TGF-β signalling

 TGF-β [μg/L]

33.3 (16.7–73.7)

39.3 (22.5–58.0)

32.8 (16.7–73.7)

0.178

 TGF-β/GAPDH [-]

0.53 (0.06–3.36)

1.07 (0.21–3.36)

0.52 (0.06–2.66)

0.016

 TGF-β RI/GAPDH [-]

2.05 (0.14–28.81)

6.41 (1.31–28.81)

1.90 (0.14–22.39)

<0.001

 TGF-β RII/GAPDH [-]

1.67 (0.51–14.85)

3.00 (0.91–10.80)

1.59 (0.51–14.85)

0.099

 miR–21 [copies/pg RNA]

2400 (57–5720)

979 (498–3640)

2815 (57–4720)

<0.001

Co-morbidities

 Obesity [n (%)]

32 (36.4 %)

10 (47.6 %)

22 (32.8 %)

0.162

 Hyperlipidemia [n (%)]

32 (36.4 %)

3 (14.2 %)

29 (43.3 %)

0.016

 Diabetes Type II [n (%)]

14 (15.9 %)

3 (14.3 %)

11 (16.4 %)

0.816

 Hypertension [n (%)]

70 (79.5 %)

17 (81.0 %)

53 (79.1 %)

0.855

 Cardiac diseases [n (%)]

27 (30.7 %)

7 (33.3 %)

20 (29.9 %)

0.763

 Osteoporosis [n (%)]

35 (39.8 %)

9 (42.9 %)

26 (38.8 %)

0.741

 History of cancer [n (%)]

12 (13.6 %)

3 (14.3 %)

9 (13.4 %)

0.921

  1. Data for continuous variables are shown as medians (min–max). For co-morbidities, the respective numbers of affected participants were determined at the medical entrance examination. Obesity was defined as a BMI of >30 kg/m2. Differences between groups were determined by Mann–Whitney U or X 2 tests; significant differences are marked in bold